Logo image of AVAV

AEROVIRONMENT INC (AVAV) Stock Fundamental Analysis

USA - NASDAQ:AVAV - US0080731088 - Common Stock

243 USD
+1.19 (+0.49%)
Last: 9/12/2025, 8:00:01 PM
243 USD
0 (0%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AVAV. AVAV was compared to 68 industry peers in the Aerospace & Defense industry. AVAV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AVAV is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AVAV had positive earnings in the past year.
In the past year AVAV has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AVAV reported negative net income in multiple years.
In multiple years AVAV reported negative operating cash flow during the last 5 years.
AVAV Yearly Net Income VS EBIT VS OCF VS FCFAVAV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

With a decent Return On Assets value of 3.89%, AVAV is doing good in the industry, outperforming 61.76% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.92%, AVAV is in line with its industry, outperforming 51.47% of the companies in the same industry.
The Return On Invested Capital of AVAV (4.93%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.89%
ROE 4.92%
ROIC 4.93%
ROA(3y)-3.87%
ROA(5y)-1.91%
ROE(3y)-6.6%
ROE(5y)-3.34%
ROIC(3y)N/A
ROIC(5y)N/A
AVAV Yearly ROA, ROE, ROICAVAV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 5.32%, AVAV is in line with its industry, outperforming 58.82% of the companies in the same industry.
In the last couple of years the Profit Margin of AVAV has declined.
AVAV has a Operating Margin of 7.21%. This is comparable to the rest of the industry: AVAV outperforms 51.47% of its industry peers.
AVAV's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 38.83%, AVAV is doing good in the industry, outperforming 76.47% of the companies in the same industry.
AVAV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.21%
PM (TTM) 5.32%
GM 38.83%
OM growth 3YN/A
OM growth 5Y-10.88%
PM growth 3YN/A
PM growth 5Y-13.83%
GM growth 3Y7.02%
GM growth 5Y-1.41%
AVAV Yearly Profit, Operating, Gross MarginsAVAV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVAV is destroying value.
The number of shares outstanding for AVAV has been increased compared to 1 year ago.
The number of shares outstanding for AVAV has been increased compared to 5 years ago.
AVAV has a worse debt/assets ratio than last year.
AVAV Yearly Shares OutstandingAVAV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AVAV Yearly Total Debt VS Total AssetsAVAV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

AVAV has an Altman-Z score of 32.82. This indicates that AVAV is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AVAV (32.82) is better than 98.53% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that AVAV is not too dependend on debt financing.
AVAV's Debt to Equity ratio of 0.03 is amongst the best of the industry. AVAV outperforms 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 32.82
ROIC/WACC0.51
WACC9.6%
AVAV Yearly LT Debt VS Equity VS FCFAVAV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

AVAV has a Current Ratio of 3.52. This indicates that AVAV is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.52, AVAV is doing good in the industry, outperforming 76.47% of the companies in the same industry.
AVAV has a Quick Ratio of 2.69. This indicates that AVAV is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.69, AVAV belongs to the best of the industry, outperforming 80.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 2.69
AVAV Yearly Current Assets VS Current LiabilitesAVAV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

8

3. Growth

3.1 Past

AVAV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.53%.
Measured over the past years, AVAV shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.43% on average per year.
Looking at the last year, AVAV shows a quite strong growth in Revenue. The Revenue has grown by 14.50% in the last year.
AVAV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.44% yearly.
EPS 1Y (TTM)-7.53%
EPS 3Y38.53%
EPS 5Y12.43%
EPS Q2Q%-64.04%
Revenue 1Y (TTM)14.5%
Revenue growth 3Y22.57%
Revenue growth 5Y17.44%
Sales Q2Q%139.96%

3.2 Future

The Earnings Per Share is expected to grow by 24.53% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 34.44% on average over the next years. This is a very strong growth
EPS Next Y4.96%
EPS Next 2Y18.57%
EPS Next 3Y24.17%
EPS Next 5Y24.53%
Revenue Next Year153.96%
Revenue Next 2Y71.56%
Revenue Next 3Y50.54%
Revenue Next 5Y34.44%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AVAV Yearly Revenue VS EstimatesAVAV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
AVAV Yearly EPS VS EstimatesAVAV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 90.00, the valuation of AVAV can be described as expensive.
AVAV's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.30. AVAV is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 52.86 indicates a quite expensive valuation of AVAV.
The rest of the industry has a similar Price/Forward Earnings ratio as AVAV.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, AVAV is valued quite expensively.
Industry RankSector Rank
PE 90
Fwd PE 52.86
AVAV Price Earnings VS Forward Price EarningsAVAV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVAV is valued a bit more expensive than the industry average as 61.76% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 121.04
AVAV Per share dataAVAV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AVAV does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as AVAV's earnings are expected to grow with 24.17% in the coming years.
PEG (NY)18.13
PEG (5Y)7.24
EPS Next 2Y18.57%
EPS Next 3Y24.17%

0

5. Dividend

5.1 Amount

No dividends for AVAV!.
Industry RankSector Rank
Dividend Yield N/A

AEROVIRONMENT INC

NASDAQ:AVAV (9/12/2025, 8:00:01 PM)

After market: 243 0 (0%)

243

+1.19 (+0.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)09-09 2025-09-09/amc
Earnings (Next)12-02 2025-12-02
Inst Owners58.92%
Inst Owner Change1.54%
Ins Owners0.77%
Ins Owner Change-95.96%
Market Cap12.13B
Analysts86.32
Price Target297.86 (22.58%)
Short Float %6.92%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.8%
Min EPS beat(2)-53.02%
Max EPS beat(2)13.42%
EPS beat(4)2
Avg EPS beat(4)-10.25%
Min EPS beat(4)-53.02%
Max EPS beat(4)34.58%
EPS beat(8)6
Avg EPS beat(8)58.73%
EPS beat(12)6
Avg EPS beat(12)12.97%
EPS beat(16)9
Avg EPS beat(16)11.8%
Revenue beat(2)1
Avg Revenue beat(2)-2.34%
Min Revenue beat(2)-16.31%
Max Revenue beat(2)11.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-16.31%
Max Revenue beat(4)11.62%
Revenue beat(8)7
Avg Revenue beat(8)3.25%
Revenue beat(12)10
Avg Revenue beat(12)3.51%
Revenue beat(16)11
Avg Revenue beat(16)0.94%
PT rev (1m)2.89%
PT rev (3m)58.1%
EPS NQ rev (1m)8.35%
EPS NQ rev (3m)-67.44%
EPS NY rev (1m)1.7%
EPS NY rev (3m)-20.34%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)87.9%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)86.29%
Valuation
Industry RankSector Rank
PE 90
Fwd PE 52.86
P/S 14.79
P/FCF N/A
P/OCF N/A
P/B 13.69
P/tB 20.88
EV/EBITDA 121.04
EPS(TTM)2.7
EY1.11%
EPS(NY)4.6
Fwd EY1.89%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS16.44
BVpS17.75
TBVpS11.64
PEG (NY)18.13
PEG (5Y)7.24
Profitability
Industry RankSector Rank
ROA 3.89%
ROE 4.92%
ROCE 6.24%
ROIC 4.93%
ROICexc 5.15%
ROICexgc 7.76%
OM 7.21%
PM (TTM) 5.32%
GM 38.83%
FCFM N/A
ROA(3y)-3.87%
ROA(5y)-1.91%
ROE(3y)-6.6%
ROE(5y)-3.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-16.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-21.5%
OM growth 3YN/A
OM growth 5Y-10.88%
PM growth 3YN/A
PM growth 5Y-13.83%
GM growth 3Y7.02%
GM growth 5Y-1.41%
F-Score2
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.3
Cap/Depr 55.65%
Cap/Sales 2.78%
Interest Coverage 33.67
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.52
Quick Ratio 2.69
Altman-Z 32.82
F-Score2
WACC9.6%
ROIC/WACC0.51
Cap/Depr(3y)46.34%
Cap/Depr(5y)46.82%
Cap/Sales(3y)2.98%
Cap/Sales(5y)3.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.53%
EPS 3Y38.53%
EPS 5Y12.43%
EPS Q2Q%-64.04%
EPS Next Y4.96%
EPS Next 2Y18.57%
EPS Next 3Y24.17%
EPS Next 5Y24.53%
Revenue 1Y (TTM)14.5%
Revenue growth 3Y22.57%
Revenue growth 5Y17.44%
Sales Q2Q%139.96%
Revenue Next Year153.96%
Revenue Next 2Y71.56%
Revenue Next 3Y50.54%
Revenue Next 5Y34.44%
EBIT growth 1Y-19.8%
EBIT growth 3YN/A
EBIT growth 5Y4.66%
EBIT Next Year303.52%
EBIT Next 3Y84.48%
EBIT Next 5Y55.2%
FCF growth 1Y-162.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.62%
OCF growth 3YN/A
OCF growth 5YN/A